Skip to main content
. 2021 Mar 18;11:6350. doi: 10.1038/s41598-021-85788-0

Table 1.

Demographic, clinical, and laboratory parameters of the participants.

Parameter Control donors Mild COVID–19 Severe COVID-19 P-value
Demographic features
Sex F:17–62.9% F:9–47.4% F:17–36.9% 0.098
F: Female M:10– 37.1% M:11–52.6% M:29–63.0%
M: Male Total: 27 Total: 19 Total: 46
Age (Average-SD) 35.4 ± 8.8 40.7 ± 10.7 49.6 ± 13.6 2.658 × 10–5
BMI (Average SD) 26.9 ± 4.3 26.9 ± 3.4 27.8 ± 3.8 0.011
Comorbidities
Overweight 11/27—40.7% 3/19—15% 15/46—32% 0.195
Obesity 5/27—18.5% 3/19—15% 20/46—42.6% 0.014
DM2 2/27– 7.4% 2/19—10% 12/46—25.5% 0.085
Hypertension 1/27—3.7% 1/19—5% 17/46—36.2% 5.697 × 10–4
Cardiopathy 0–0% 0—0% 5/46—10.6% 0.1146
Vital signs
Temp (ºC) 37.4 ± 0.7 37.2 ± 0.8 0.095
Hearth rate (bpm) 101.3 ± 19.3 103.6 ± 17.0 0.680
Respiratory rate (bpm) 20.1 ± 3.8 25.2 ± 6.5 0.002
Mean arterial pressure (mmHg) 95.1 ± 11.6 97.6 ± 14.9 0.982
SO2 (%) 94.8 ± 1.4 86.5 ± 9.2 4.889 × 10–8
Symptoms
Cough 15/19—75% 38/46—80.9% 0.734
Headache 15/19—75% 24/46—51.1% 0.055
Fever 16/19—80% 42/46—89.4% 0.407
Dyspnea 5/19—25% 33/46—70.2% 0.001
Arthralgia 11/19—55% 26/46—55.3% 0.999
Myalgia 11/19—55% 31/46—66% 0.570
Sore Throat 5/19—25% 15/46—31.9% 0.770
Nausea 1/19—5% 4/46—8.5% 0.999
Diarrhea 2/19—10% 10/46—21.3% 0.483
Fatigue 9/19—45% 20/46—42.5% 0.790
Arterial blood gases
FiO2 (%) 27.9 ± 12.6
pH art 7.33 ± 0.2
Arterial PO2 (mmHg) 83.7 ± 43.2
Arterial PCO2 (mmHg) 28.9 ± 3.7
HCO3 (mmol/L) 21.4 ± 2.8
Lactate (mmol/L) 1.67 ± 0.9
PAFI 265.7 ± 104.3
Anion gap (mmol/L) 14.3 ± 2.4
Laboratory tests
Glucose (mg/dL) 134.04 ± 76.2
CRP (mg/dL) 13.3 ± 8.4
Ferritin (ng/mL) 555.3 ± 408.2
DHL (U/L) 373.07 ± 162.8
ALT (U/L) 39.06 ± 36.5
AST (U/L) 41.6 ± 29.7
Creatinine (mg/dL) 0.97 ± 0.3
Albumin (g/dL) 3.99 ± 0.8

P-value for Kruskal–Wallis, U, cχ2 or Fisher exact test.